The p27 Kip1 protein is a negative regulator of the cell cycle and a potential tumor suppressor gene. Reduced expression of the p27 Kip1 protein has been reported in several human tumors and has been associated with higher tumor grade and increased mortality in breast, lung, colon, prostate, bladder
Prognostic impact of cyclin-dependent kinase inhibitor p27kip1 in node-positive breast cancer
โ Scribed by Tsuchiya, Atsuo; Zhang, Guo Jun; Kanno, Masahiko
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 97 KB
- Volume
- 70
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
โฆ Synopsis
Background and objectives:
P27kip1 (p27) plays an important role as a negative regulator of cell cycle-dependent kinase activity during progression of the cell cycle. the most important prognosticator of breast cancer is nodal status, and the aim of this study was to determine the prognostic implication of p27 in breast cancer patients with lymph node metastases.
Methods:
Immunohistochemical staining for p27 was performed on tissues from 102 patients with node-positive breast cancer.
Results:
A nuclear staining over 50% was defined as high expression. high expression of p27 was shown in 59 patients (57.8%). a significant correlation was found between high p27 and positive estrogen receptor status, but there was no correlation between p27 staining and age, menopausal status, nodal status, or tumor size. low expression of p27 was significantly associated with shorter survival. a multivariate analysis also showed that the only independent variable was p27.
Conclusions:
The results indicated that low expression of p27 was an independent factor associated with poor prognosis. therefore, p27 can be an important tool in making therapeutic decisions.
๐ SIMILAR VOLUMES
## BACKGROUND. Low expression of p27 kip1 , a dominant cyclin-dependent kinase inhibitor involved in G1-S transition of the cell cycle, recently has been reported to be associated with aggressive tumor growth. It has been shown that active cell proliferation alludes to poor prognosis in patients w
Terminal cellular differentiation is generally accompanied by exit from the cell cycle but the molecular basis of how the two events are coupled is poorly understood. In the central nervous system (CNS) the terminally differentiated, non-proliferating myelin-synthesizing cells, oligodendrocytes, ari